Cargando…
Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination
Understanding the T-cell responses involved in inhibiting COVID-19 severity is crucial for developing new therapeutic and vaccine strategies. Here, we characterized SARS-CoV-2 spike-specific CD8(+) T cells in vaccinees longitudinally. The BNT162b2 mRNA vaccine can induce spike-specific CD8(+) T cell...
Autores principales: | Nogimori, Takuto, Suzuki, Koichiro, Masuta, Yuji, Washizaki, Ayaka, Yagoto, Mika, Ikeda, Mami, Katayama, Yuki, Kanda, Hidenori, Takada, Minoru, Minami, Shohei, Kobayashi, Takeshi, Takahama, Shokichi, Yoshioka, Yasuo, Yamamoto, Takuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845949/ https://www.ncbi.nlm.nih.gov/pubmed/36685601 http://dx.doi.org/10.3389/fimmu.2022.1081047 |
Ejemplares similares
-
Assessment of Fcγ receptor-dependent binding of influenza hemagglutinin vaccine-induced antibodies in a non-human primate model
por: Masuta, Yuji, et al.
Publicado: (2022) -
Model for predicting age-dependent safety and immunomodulatory effects of STING ligands in non-human primates
por: Takahama, Shokichi, et al.
Publicado: (2022) -
Elucidation of the role of nucleolin as a cell surface receptor for nucleic acid-based adjuvants
por: Kitagawa, Satoki, et al.
Publicado: (2022) -
Pattern Recognition Receptor Ligands as an Emerging Therapeutic Agent for Latent HIV-1 Infection
por: Takahama, Shokichi, et al.
Publicado: (2020) -
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study
por: Akahata, Wataru, et al.
Publicado: (2023)